In recent years, incretins such as the GLP-1 receptor agonists have proven effective in the control of hyperglycemia but also in weight loss, where they are now separately approved as a treatment for obesity. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.